Exagen Inc. (XGN) stock
XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$3.61−0.19 (-5.00%)
Close on Nov 20, 2026Market cap $87.45MP/E –Yield –
Exagen free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Exagen's free cash flow for the twelve months ending Jun 30, 2026 was -$7.59M. For fiscal 2025 it was -$14.27M. The highest annual figure on record is -$9.50M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.27M | – |
| FY2024 | Dec 31, 2024 | -$13.79M | – |
| FY2023 | Dec 31, 2023 | -$15.29M | – |
| FY2022 | Dec 31, 2022 | -$36.46M | – |
| FY2021 | Dec 31, 2021 | -$22.64M | – |
| FY2020 | Dec 31, 2020 | -$14.54M | – |
| FY2019 | Dec 31, 2019 | -$10.11M | – |
| FY2018 | Dec 31, 2018 | -$9.50M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.45M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.65M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.06M | -1508.8% |
| Q3 FY2025 | Sep 30, 2025 | $2.67M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.09M | – |
| Q1 FY2025 | Mar 31, 2025 | -$10.78M | – |
| Q4 FY2024 | Dec 31, 2024 | $217.00K | -97.4% |
| Q3 FY2024 | Sep 30, 2024 | -$2.32M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.56M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.13M | – |
| Q4 FY2023 | Dec 31, 2023 | $8.24M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.91M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.48M | – |
| Q1 FY2023 | Mar 31, 2023 | -$10.15M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.14M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.56M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.10M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.66M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.11M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.89M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.16M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.48M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.90M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.34M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.91M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.39M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.95M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.67M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.18M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.31M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.94M | – |
See a number that looks wrong?